Evidence map›Paper›PMID 37380995›Full record

ArticleHarm reduction journal2023

Impact of safer supply programs on injection practices: client and provider experiences in Ontario, Canada.

Marilou Gagnon, Katherine Rudzinski, Adrian Guta, Rose A Schmidt, David T Kryszajtys, Gillian Kolla, Carol Strike

Open access · goldAbstract read
In one paragraph

Article in Harm reduction journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Marilou GagnonSchool of Nursing, University of Victoria, Victoria, BC, Canada. marilougagnon@uvic.ca.
Katherine RudzinskiSchool of Social Work, University of Windsor, Windsor, ON, Canada.
Adrian GutaSchool of Social Work, University of Windsor, Windsor, ON, Canada.
Rose A SchmidtDalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
David T KryszajtysDalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Gillian KollaCanadian Institute for Substance Use Research, University of Victoria, 2300 McKenzie Avenue, Victoria, BC, V8N 5M8, Canada.
Carol StrikeDalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
University of Toronto · CAUniversity of Victoria · CAUniversity of Windsor · CAPublic Health Ontario · CA

Funding

CIHR 162938
6 · The paper itself

Abstract

objectivesFentanyl has contributed to a sharp rise in the toxicity of the unregulated drug supply and fatal overdoses in Canada. It has also changed injection practices. Injection frequency has increased as a result and so has equipment sharing and health-related risks. The aim of this analysis was to explore the impact of safer supply programs on injection practices from the perspective of clients and providers in Ontario, Canada.

methodsThe data set included qualitative interviews with 52 clients and 21 providers that were conducted between February and October 2021 across four safer supply programs. Interview excerpts discussing injection practices were extracted, screened, coded and then grouped into themes.

resultsWe identified three themes, each theme corresponding to a change in injection practices. The first change was a decrease in the amount of fentanyl used and a decrease in injection frequency. The second change involved switching to injecting hydromorphone tablets instead of fentanyl. Finally, the third change was stopping injecting altogether and taking safer supply medications orally.

conclusionSafer supply programs can contribute to reducing injection-related health risks in addition to overdose risks. More specifically, they have the potential to address disease prevention and health promotion gaps that stand-alone downstream harm reduction interventions cannot address, by working upstream and providing a safer alternative to fentanyl.

Indexed as

Drug OverdoseFentanylHarm ReductionHealth PromotionHumansOntarioFentanylDrugsFentanylInjectionOverdoseQualitative researchSafer supplySubstance use

Identifiers

PMID37380995
PMCPMC10303300
OpenAlexW4382400579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.